Roche ties up again with Ascletis — this time on a commercial partnership for hep B drug
In the spring of 2013, Roche teamed up with a 2-year-old biotech to commercialize one of its hepatitis C drugs in China without making much …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
